Company Filing History:
1 out of 38 
1 out of 55 
1 out of 4 Years Active: 2025
Title: Magdiel Perez-Cruz: Innovator in Chronic Obstructive Pulmonary Disease Treatment
Introduction
Magdiel Perez-Cruz is a notable inventor based in Lille, France. He has made significant contributions to the field of medicine, particularly in the treatment of chronic obstructive pulmonary disease (COPD). His innovative approach focuses on the antagonism of the IL-20 receptor, which has implications for managing acute exacerbations of this debilitating condition.
Latest Patents
Magdiel Perez-Cruz holds a patent titled "Treatment of acute exacerbations of chronic obstructive pulmonary disease by antagonism of the IL-20R." This invention relates to methods and pharmaceutical compositions aimed at treating acute exacerbations of COPD. The patent outlines a method for administering a therapeutically effective amount of an antagonist of IL-20 cytokines to patients in need.
Career Highlights
Throughout his career, Magdiel has worked with esteemed organizations such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Institut Pasteur de Lille. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Magdiel has collaborated with notable colleagues, including Philippe Gosset and Muriel Pichavant. These partnerships have enriched his research and fostered innovation in the field of respiratory diseases.
Conclusion
Magdiel Perez-Cruz is a pioneering inventor whose work in treating chronic obstructive pulmonary disease has the potential to improve the lives of many patients. His dedication to research and innovation continues to make a significant impact in the medical field.